Lawrence Rosman
Endocrinology, Diabetes & Metabolism · Forest Hills, NYNPI 1063405652
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.6% of the total across 121 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 14.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $720 and has fallen 96.6% since, to $24 in 2025.
Across 121 payments — averaging $22.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amneal Pharmaceuticals LLC$379
- Lilly USA, LLC$362
- Amgen$316
- Sanofi-aventis U.S. LLC$298
- AstraZeneca$251
- Novo Nordisk$216
- plus $864 from 18 others
What the payments were for
- Food & beverage$2,64899%
- Education$381%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amneal Pharmaceuticals LLC | 15 | $379 |
| Lilly USA, LLC | 16 | $362 |
| Amgen(2 entities) | 13 | $316 |
| Sanofi-aventis U.S. LLC | 12 | $298 |
| AstraZeneca(2 entities) | 15 | $251 |
| Novo Nordisk | 11 | $216 |
| AbbVie | 6 | $127 |
| Mannkind Corporation | 5 | $112 |
| Dexcom, Inc. | 4 | $85 |
| Xeris Pharmaceuticals, Inc. | 4 | $80 |
| Johnson & Johnson | 2 | $59 |
| BD | 2 | $54 |
| Ultragenyx Pharmaceutical Inc. | 2 | $53 |
| Radius Health, Inc. | 2 | $48 |
| Merck | 2 | $43 |
| Boehringer Ingelheim | 2 | $43 |
| Kowa Pharmaceuticals America, Inc. | 1 | $25 |
| Amarin Pharma, Inc. | 1 | $23 |
| Bigfoot Biomedical Inc | 1 | $22 |
| IBSA Pharma Inc. | 1 | $22 |
| Esperion Therapeutics, Inc. | 1 | $19 |
| Vivus LLC | 1 | $18 |
| Senseonics, Incorporated | 1 | $17 |
| Pfizer | 1 | $14 |
How this compares
$2,686 in reported general payments places this provider in the 65th percentile of 804 endocrinology, diabetes & metabolism providers in New York.
See all endocrinology, diabetes & metabolism providers in New York →
Other endocrinology, diabetes & metabolism in Forest Hills
- Robert BuschAlbany$2.7M
- Michael ShanikSmithtown$1.2M
- Ajay ChaudhuriBuffalo$888K
- Vinay KapoorManhasset$820K
- John BilezikianNew York$809K
- Barbara HirschManhasset$746K
- Martin GrajowerBronx$713K
- Anastasios ManessisNew York$656K
- Jonas LeibowitzYonkers$613K
- Philip OtterbeckStaten Island$575K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.